Search Results - Kenneth E. Palmer

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis by Henry W. Nabeta, Henry W. Nabeta, Amanda B. Lasnik, Joshua L. Fuqua, Joshua L. Fuqua, Lin Wang, Lisa C. Rohan, Lisa C. Rohan, Lisa C. Rohan, Kenneth E. Palmer, Kenneth E. Palmer, Kenneth E. Palmer

    Get full text
    Article


  2. 2

    Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses by Christopher Barton, J. Calvin Kouokam, Harrell Hurst, Kenneth E. Palmer

    Published in Viruses (2016-12-01)
    Get full text
    Article


  3. 3

    Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL) by Elizabeth Cash, Kailyn Deitz, Kevin L Potts, Henry W Nabeta, Maryam Zahin, Shesh N Rai, Gerald W Dryden, Kenneth E Palmer

    Published in BMJ Open (2023-09-01)
    Get full text
    Article


  4. 4

    Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination by Alok R. Amraotkar, Adrienne M. Bushau-Sprinkle, Rachel J. Keith, Krystal T. Hamorsky, Kenneth E. Palmer, Hong Gao, Shesh N. Rai, Aruni Bhatnagar

    Published in Vaccines (2022-08-01)
    Get full text
    Article


  5. 5

    Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate. by Joseph Calvin Kouokam, Dana Huskens, Dominique Schols, Andrew Johannemann, Shonna K Riedell, Wendye Walter, Janice M Walker, Nobuyuki Matoba, Barry R O'Keefe, Kenneth E Palmer

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  6. 6

    Dynamic SARS-CoV-2 surveillance model combining seroprevalence and wastewater concentrations for post-vaccine disease burden estimates by Rochelle H. Holm, Grzegorz A. Rempala, Boseung Choi, J. Michael Brick, Alok R. Amraotkar, Rachel J. Keith, Eric C. Rouchka, Julia H. Chariker, Kenneth E. Palmer, Ted Smith, Aruni Bhatnagar

    Published in Communications Medicine (2024-04-01)
    Get full text
    Article


  7. 7

    A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4+ cell distribution in the human rectal mucosa by Mathias Franzén Boger, Nora Benhach, Tyra Hasselrot, Rhonda M. Brand, Lisa C. Rohan, Lin Wang, Ian McGowan, Stacey Edick, Ken Ho, Leslie Meyn, Nobuyuki Matoba, Kenneth E. Palmer, Kristina Broliden, Annelie Tjernlund

    Published in Scientific Reports (2023-05-01)
    Get full text
    Article


  8. 8

    NMDA receptor antagonists mitigate COVID-19-induced neuroinflammation and improve survival in a mouse model by Emily R. Prantzalos, Jane P. Chesser, Judy Songrady Logan, Kristen A. McLaurin, Charles D. Anderson, Jon D. Gabbard, William E. Severson, Kenneth E. Palmer, Bobbi Jo Mullins, Linda Dwoskin, Jill R. Turner

    Published in Scientific Reports (2025-06-01)
    Get full text
    Article


  9. 9

    CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associa... by Jennifer K. DeMarco, Joshua M. Royal, William E. Severson, Jon D. Gabbard, Steve Hume, Josh Morton, Kelsi Swope, Carrie A. Simpson, John W. Shepherd, Barry Bratcher, Kenneth E. Palmer, Gregory P. Pogue

    Published in Vaccines (2021-11-01)
    Get full text
    Article


  10. 10

    Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville C... by Lalit Batra, Divyasha Saxena, Triparna Poddar, Maryam Zahin, Alok Amraotkar, Megan M. Bezold, Kathleen T. Kitterman, Kailyn A. Deitz, Amanda B. Lasnik, Rachel J. Keith, Aruni Bhatnagar, Maiying Kong, Jon D. Gabbard, William E. Severson, Kenneth E. Palmer

    Published in Vaccines (2025-05-01)
    Get full text
    Article


  11. 11

    CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection by Jian Zheng, Hima Dhakal, Enya Qing, Rejeena Shrestha, Anne E. Geller, Samantha M. Morrissey, Divyasha Saxena, Xiaoling Hu, Hong Li, Haiyan Li, Kevin Wilhelmsen, Linder H. Wendt, Klaus Klumpp, Patrick S. Hume, William J. Janssen, Rachel Brody, Kenneth E. Palmer, Silvia M. Uriarte, Patrick Ten Eyck, David K. Meyerholz, Michael L. Merchant, Kenneth McLeish, Tom Gallagher, Jiapeng Huang, Jun Yan, Stanley Perlman

    Published in The Journal of Clinical Investigation (2025-02-01)
    Get full text
    Article


Search Tools: